Baker Hughes Offers Remedies to EU for Antitrust Approval of Chart Deal
Baker Hughes has submitted remedies to the European Commission to secure antitrust approval for its $13.6 billion acquisition of Chart Industries, according to a Commission filing released Monday. The company did not disclose details of the proposed concessions.
Baker Hughes has submitted remedies to the European Commission in an effort to secure antitrust approval for its $13.6 billion acquisition of Chart Industries, according to a Commission filing published Monday.
The oilfield services company is navigating EU regulatory scrutiny of the transaction, which would combine Baker Hughes' energy infrastructure capabilities with Chart's cryogenic equipment and clean energy assets. The Commission filing did not specify the nature of the proposed remedies, which typically include asset divestitures, licensing agreements, or behavioral commitments designed to preserve competition in overlapping markets.
Continue reading
3 more paragraphs for subscribers.
Free readers get a daily preview and the weekly long-form. Premium unlocks every brief in full, AM & PM editions, alerts, and the archive.